Broad-Based Technical Strength Lifts Acutaas Chemicals Ltd to 52-Week High of Rs 2719.6

May 05 2026 09:49 AM IST
share
Share Via
Surging past its previous peaks, Acutaas Chemicals Ltd touched a new 52-week high of Rs 2719.6 on 05 May 2026, marking a remarkable 119.63% gain over the past year. This milestone comes amid a backdrop of strong technical momentum, even as the broader Sensex trades lower, underscoring the stock’s distinctive upward trajectory.
Broad-Based Technical Strength Lifts Acutaas Chemicals Ltd to 52-Week High of Rs 2719.6

Market Context and Price Milestone

While the Sensex opened 165.68 points lower and currently trades at 76,978.80, down 0.38%, Acutaas Chemicals Ltd has defied the broader market weakness. The stock’s 52-week low was Rs 1059.05, highlighting an extraordinary rally that more than doubled its value in twelve months. Despite a slight pullback of 1.25% on the day, the stock remains comfortably above all key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — signalling sustained bullish momentum. Acutaas Chemicals Ltd’s outperformance against the Sensex’s negative trend raises the question of what factors have enabled such resilience in a challenging market environment?

Technical Indicators Paint a Clear Picture of Strength

The technical landscape for Acutaas Chemicals Ltd is overwhelmingly positive, with multiple indicators aligning to confirm the uptrend. On the weekly and monthly charts, the Moving Average Convergence Divergence (MACD) is bullish, reflecting strong momentum and confirming the recent price breakout. Bollinger Bands on both timeframes also signal bullishness, with the stock price riding the upper band, indicative of sustained buying pressure.

Meanwhile, the Know Sure Thing (KST) oscillator supports this momentum, showing bullish readings on weekly and monthly scales. Daily moving averages reinforce this trend, with the stock trading above all major averages, a classic hallmark of a robust uptrend. However, the Relative Strength Index (RSI) on weekly and monthly charts currently shows no clear signal, suggesting the stock is not yet in overbought territory, which could imply room for further momentum.

Interestingly, Dow Theory does not confirm a definitive trend on weekly or monthly charts, and On-Balance Volume (OBV) remains neutral, indicating volume has not decisively confirmed price moves. This divergence between price momentum and volume-based indicators invites a closer look at the sustainability of the rally. Could this mixed volume signal hint at a potential pause or consolidation ahead despite strong price action?

Strong fundamentals, steady climb upward! This Large Cap from Telecommunication sector earned its Reliable Performer badge through consistent execution. Safety meets solid returns here!

  • - Reliable Performer certified
  • - Consistent execution proven
  • - Large Cap safety pick

Get Safe Returns →

Quarterly Results and Fundamental Momentum

The technical strength is underpinned by solid fundamental performance. Acutaas Chemicals Ltd has reported seven consecutive quarters of positive results, with net sales growing at an annualised rate of 26.68% and operating profit margins expanding to 47.03%. The latest quarter saw net sales reach Rs 432.75 crores, the highest recorded, while net profit grew by 26.42%, reinforcing the company’s earnings power.

Return on Capital Employed (ROCE) stands at an impressive 28.77% for the half-year, signalling efficient capital utilisation. Inventory turnover ratio is also robust at 5.79 times, reflecting effective working capital management. Institutional investors hold a significant 39.1% stake, having increased their position by 0.72% over the previous quarter, which often signals confidence in the company’s prospects. How much of the recent price momentum is justified by these strong quarterly fundamentals?

Key Data at a Glance

52-Week High: Rs 2719.6
52-Week Low: Rs 1059.05
1-Year Return: 119.63%
Sensex 1-Year Return: -4.72%
Debt to Equity (Avg): 0.05 times
ROCE (HY): 28.77%
Net Sales Growth (Annual): 26.68%
PEG Ratio: 0.5

Valuation and Risk Metrics

Despite the impressive rally, valuation metrics suggest a nuanced picture. The Price to Book Value stands at 13.2, indicating a premium valuation relative to book equity. The Return on Equity (ROE) is a strong 21.5%, but this high ROE combined with a lofty Price to Book ratio points to a valuation that is on the expensive side compared to historical averages. However, the PEG ratio of 0.5 is notably low, implying that earnings growth has outpaced price appreciation — a somewhat rare scenario for a stock at its 52-week high.

This disconnect between valuation multiples and earnings growth invites a deeper look at whether the current price fully reflects the company’s fundamental strength or if there is still room for adjustment. At a fresh 52-week high with strong earnings growth but moderate return ratios, should you buy, sell, or hold Acutaas Chemicals Ltd? The detailed multi-parameter analysis has the answer.

Want to dive deeper on Acutaas Chemicals Ltd? There's a real-time research report diving right into the fundamentals, valuations, peer comparison, financials, technicals and much more!

  • - Real-time research report
  • - Complete fundamental analysis
  • - Peer comparison included

Read the Full Verdict →

Momentum in Focus: What Lies Ahead?

The technical indicator grid for Acutaas Chemicals Ltd reveals a predominantly bullish setup, with MACD, Bollinger Bands, KST, and moving averages all signalling strength across weekly, monthly, and daily timeframes. The absence of RSI signals suggests the stock is not yet overextended, while the neutral Dow Theory and OBV readings hint at a potential need for volume confirmation to sustain the rally.

After three consecutive days of gains, the stock’s slight retreat today may represent a healthy pause rather than a reversal. The combination of strong earnings growth, low leverage, and institutional backing provides a solid foundation for the current momentum. Yet, the elevated valuation metrics and mixed volume signals warrant close monitoring. Does the current momentum justify maintaining exposure to Acutaas Chemicals Ltd, or is a consolidation phase imminent?

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News